Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.298NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.76NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.384NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.501NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.226NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.546NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.9 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.203NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.157NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.176NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.3.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.432NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.388NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.112NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.274NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.515NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.370NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.632NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.108NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.332NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAANWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N/ANWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.494NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.167NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.267NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
B.1.165NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used